Spire Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Sell |
14,100
-4,329
| -23% | -$93.9K | 0.01% | 635 |
|
|
2025
Q1 | $447K | Buy |
18,429
+4,000
| +28% | +$97K | 0.01% | 599 |
|
|
2024
Q4 | $301K | Buy |
14,429
+13,429
| +1,343% | +$280K | 0.01% | 705 |
|
|
2024
Q3 | $19.9K | Sell |
1,000
-38
| -4% | -$755 | ﹤0.01% | 1441 |
|
|
2024
Q2 | $16.1K | Hold |
1,038
| – | – | ﹤0.01% | 1514 |
|
|
2024
Q1 | $16.5K | Hold |
1,038
| – | – | ﹤0.01% | 1570 |
|
|
2023
Q4 | $15.1K | Hold |
1,038
| – | – | ﹤0.01% | 1626 |
|
|
2023
Q3 | $12.1K | Hold |
1,038
| – | – | ﹤0.01% | 1668 |
|
|
2023
Q2 | $14K | Buy |
+1,038
| New | +$14K | ﹤0.01% | 1710 |
|